Research News

January 22, 2019
Members of the George Washington University (GW) Cancer Center, including Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity, recently published several journal articles and patient-focused pieces highlighting the GW Cancer Center’s work in patient…
October 31, 2018
WASHINGTON (Oct. 31, 2018) - Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate.
October 1, 2018
Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.
September 27, 2018
WASHINGTON (Sept. 26, 2018) - Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the George Washington University (GW) School of Medicine and Health Sciences.
September 24, 2018
Dr. Adam Friedman joins breast cancer survivor Mariam Said to discuss side effects of cancer treatment and how the Supportive Oncodermatology Clinic at the GW Cancer Center is giving patients hope and resources for relief.
September 11, 2018
Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.
June 5, 2018
Researchers from the George Washington University (GW) Cancer Center recently participated in the American Society of Clinical Oncology (ASCO) Annual Meeting held June 1-5, 2018 in Chicago.
April 27, 2018
Research published in Cancer Cell by George Washington University (GW) Cancer Center researcher Alexandros Tzatsos, MD, PhD, found an important connection between the KDM6A gene and the most aggressive form of pancreatic cancer.
January 26, 2018
Rohan Fernandes, PhD, assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, received more than $700,000 from the Alex’s Lemonade Stand Foundation to research treatment for neuroblastoma, a childhood cancer that forms in certain types of nerve…
July 17, 2017
A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.